Publications by authors named "James Loyd"

Claim this Profile
T
The Genetic Landscape of Familial Pulmonary Fibrosis.
Qi Liu, Yuan Zhou, Joy D Cogan, Daphne B Mitchell, Quanhu Sheng, James E Loyd

Am J Respir Crit Care Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Progression of Fibrotic Lung Disease in an At-Risk Cohort.
Mark P Steele, Anna L Peljto, Susan K Mathai, Stephen Humphries, Tami J Bang, James E Loyd

Am J Respir Crit Care Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral Blood Telomere Attrition in Persons at Risk for Familial Pulmonary Fibrosis.
Margaret L Salisbury, Cheryl R Markin, Pingsheng Wu, Joy D Cogan, Daphne B Mitchell, James E Loyd

Am J Respir Crit Care Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association between Exposures and Disease Characteristics in Familial Pulmonary Fibrosis.
Carla R Copeland, Edwin F Donnelly, Mitra Mehrad, Guixiao Ding, Cheryl R Markin, James E Loyd

Ann Am Thorac Soc· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postdeployment Respiratory Syndrome in Soldiers With Chronic Exertional Dyspnea.
Sergey S Gutor, Bradley W Richmond, Rui-Hong Du, Pingsheng Wu, Kim L Sandler, James E Loyd

Am J Surg Pathol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case series of pediatric mediastinal granuloma related to histoplasmosis.
Katherine Carr, James Loyd, Robert Lentz, Melissa Danko, Michael O'Connor

Pediatr Pulmonol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Randomized, Controlled, Clinical Trial of Valganciclovir in Idiopathic Pulmonary Fibrosis.
Timothy S Blackwell, Justin C Hewlett, Wendi R Mason, Susan Martin, James Del Greco, James E Loyd

Ann Am Thorac Soc· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4CTLs in Fibrosing Mediastinitis Linked to .
Hugues Allard-Chamard, Faisal Alsufyani, Naoki Kaneko, Kelly Xing, Cory Perugino, James Loyd

J Immunol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of a Human Caveolin-1 Mutation in Mice Drives Inflammatory and Metabolic Defect-Associated Pulmonary Arterial Hypertension.
Anandharajan Rathinasabapathy, Courtney Copeland, Amber Crabtree, Erica J Carrier, Christy Moore, James E Loyd

Front Med (Lausanne)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis.
Arun C Habermann, Austin J Gutierrez, Linh T Bui, Stephanie L Yahn, Nichelle I Winters, James E Loyd

Sci Adv· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease.
Margaret L Salisbury, Justin C Hewlett, Guixiao Ding, Cheryl R Markin, Katrina Douglas, James E Loyd

Am J Respir Crit Care Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Concepts in the Epidemiology, Diagnosis, and Management of Histoplasmosis Syndromes.
Marwan M Azar, James L Loyd, Ryan F Relich, L Joseph Wheat, Chadi A Hage

Semin Respir Crit Care Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex hormone exposure and reproductive factors in pulmonary arterial hypertension: a case-control study.
Jessica B Badlam, David Badesch, Evan Brittain, Shannon Cordell, Tan Ding, James Loyd

Pulm Circ· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis.
Susan K Mathai, Stephen Humphries, Jonathan A Kropski, Timothy S Blackwell, Julia Powers, James E Loyd

Thorax· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.
Camille Moore, Rachel Z Blumhagen, Ivana V Yang, Avram Walts, Julie Powers, James E Loyd

Am J Respir Crit Care Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension.
Svenja Dannewitz Prosseda, Xuefei Tian, Kazuya Kuramoto, Mario Boehm, Deepti Sudheendra, James E Loyd

Am J Respir Crit Care Med· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetics and genomics of pulmonary arterial hypertension.
Nicholas W Morrell, Micheala A Aldred, Wendy K Chung, C Gregory Elliott, William C Nichols, James E Loyd

Eur Respir J· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Status and Future Opportunities in Lung Precision Medicine Research with a Focus on Biomarkers. An American Thoracic Society/National Heart, Lung, and Blood Institute Research Statement.
Ann Chen Wu, James P Kiley, Patricia J Noel, Shashi Amur, Esteban G Burchard, James E Loyd

Am J Respir Crit Care Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension.
Anna R Hemnes, Anandharajan Rathinasabapathy, Eric A Austin, Evan L Brittain, Erica J Carrier, James E Loyd

Eur Respir J· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-Wide Association Study of 58 Individuals with Fibrosing Mediastinitis Reveals Possible Underlying Genetic Susceptibility.
Bradley W Richmond, Yan Guo, Chang Yu, Peggy L Kendall, Wendi R Mason, James E Loyd

Am J Respir Crit Care Med· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?
Paul J Wolters, Timothy S Blackwell, Oliver Eickelberg, James E Loyd, Naftali Kaminski

Lancet Respir Med· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A disease-associated frameshift mutation in caveolin-1 disrupts caveolae formation and function through introduction of a de novo ER retention signal.
Courtney A Copeland, Bing Han, Ajit Tiwari, Eric D Austin, James E Loyd

Mol Biol Cell· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetics of Pulmonary Arterial Hypertension.
Joshua D Chew, James E Loyd, Eric D Austin

Semin Respir Crit Care Med· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.
Xinping Chen, Eric D Austin, Megha Talati, Joshua P Fessel, Eric H Farber-Eger, James E Loyd

Eur Respir J· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis